GleamWall
中文EN

TNDM TANDEM DIABETES CARE INC

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1438133 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY6.8%
TTM net income YoY75.8%
TTM EPS YoY76.4%
Revenue 3-yr CAGR11.7%
Net income 3-yr CAGR—

Margins

Gross margin56.6%
Operating margin-2.4%
Net margin-4.6%
FCF margin-3.4%
EBITDA margin-0.7%

Returns

ROE-36.7%
ROA-4.8%
ROIC (approx.)-3.9%
Asset turnover1.06x

Leverage & solvency

Liabilities / assets88.3%
Debt / equity4.47x
Current ratio3.21x
Interest coverage-2.80x

Cash quality & payout

Operating cash flow / net income0.30x
Accruals ratio-3.4%
Payout ratio—
Capex / revenue2.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q42025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q42024-12-31
Income statement
Revenue$283.69M$254.56M$247.22M$290.38M$249.25M$240.68M$234.42M$282.65M
Cost of revenue$123.27M$109.78M$110.43M$122.92M$114.96M$114.82M$116.02M$125.19M
Gross profit$160.42M$144.78M$136.79M$167.46M$134.29M$125.86M$118.41M$157.46M
R&D expense$48.85M$46.93M$46.03M$46.07M$48.72M$48.12M$50.22M$52.20M
SG&A expense$113.94M$111.64M$108.19M$113.10M$108.44M$109.60M$113.85M$105.84M
Operating income-$2.37M-$13.79M-$17.43M$8.29M-$22.86M-$51.81M-$120.88M-$581,000
Interest expense$2.31M$2.45M$2.20M$2.08M$2.06M$1.91M$1.86M$1.86M
Pretax income-$7.69M-$20.66M-$19.88M$4.68M-$25.14M-$57.72M-$122.09M$16,000
Income tax-$608,000$510,000$516,000$5.27M-$3.98M-$5.32M$8.47M-$739,000
Net income-$7.08M-$21.17M-$20.39M-$589,000-$21.16M-$52.40M-$130.56M$755,000
EBITDA$2.14M-$9.32M-$12.93M$12.79M-$18.37M-$47.44M-$116.57M$3.66M
EPS (basic)-0.10-0.31-0.30-0.01-0.31-0.78-1.970.01
EPS (diluted)-0.10-0.31-0.30-0.01-0.31-0.78-1.970.01
Weighted avg. shares (diluted)69.65M69.01M68.40M68.01M67.65M67.05M66.40M66.16M
Balance sheet
Cash & equivalents$72.84M$62.82M$179.32M$90.63M$91.95M$64.11M$53.57M$69.23M
Short-term investments$370.24M$393.18M$390.93M$202.03M$227.16M$251.25M$315.05M$369.10M
Receivables$180.02M$162.06M$140.67M$165.49M$125.94M$128.44M$126.56M$114.58M
Inventory$143.12M$135.11M$126.40M$128.77M$137.28M$142.57M$141.16M$149.61M
Current assets$820.72M$804.64M$887.10M$618.14M$616.94M$614.82M$663.43M$724.49M
PP&E, net$85.14M$84.50M$83.25M$83.58M$77.92M$77.51M$79.22M$78.15M
Intangibles———$11.72M———$925,000
Total assets$1.16B$1.15B$1.15B$881.11M$874.65M$875.74M$922.14M$967.66M
Current liabilities$256.07M$253.00M$247.96M$242.72M$252.54M$251.69M$288.18M$247.05M
Short-term debt———————$40.67M
Long-term debt$603.39M$602.58M$601.77M$310.04M$309.59M$309.15M$308.70M$308.27M
Total debt$603.39M$602.58M$601.77M$310.04M$309.59M$309.15M$308.70M$348.94M
Total liabilities$1.02B$1.02B$1.02B$725.94M$741.69M$742.45M$766.85M$704.56M
Shareholders' equity$135.09M$130.39M$132.40M$155.17M$132.97M$133.28M$155.29M$263.10M
Net debt$530.55M$539.76M$422.44M$219.40M$217.64M$245.03M$255.13M$279.70M
Shares outstanding69.76M69.54M68.50M68.29M67.77M67.53M66.57M66.26M
Cash flow statement
Operating cash flow-$819,000-$34.63M$11.05M$9.79M$8.26M-$9.50M-$18.28M$10.72M
Capital expenditure$4.69M$4.05M$6.27M$6.68M$4.09M$6.21M$2.96M$3.07M
Free cash flow-$5.51M-$38.68M$4.79M$3.10M$4.17M-$15.70M-$21.24M$7.65M
Investing cash flow$17.98M-$87.34M-$195.45M-$14.98M$20.54M$58.13M$9.19M$5.01M
Financing cash flow-$7.03M$2.15M$274.16M$2.60M-$1.57M-$39.71M-$4.69M$2.30M
Depreciation & amortization$4.51M$4.47M$4.50M$4.50M$4.49M$4.37M$4.31M$4.25M
Stock-based compensation$15.90M$15.74M$15.66M$20.11M$21.14M$25.64M$25.49M$28.17M
Share buybacks———$0$0$0$0$0

Free plan shows the latest 8 periods; Pro shows all 55 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.